Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay L Hess

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|September 3, 2013
Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteinsChenxi Shen, Stephanie Y Jo, Chenzhong Liao, et al.
Blood|March 15, 2011
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocationStephanie Y Jo, Eric M Granowicz, Ivan Maillard, et al.
Cancer Research|December 17, 2005
Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modificationsThomas A Milne, Mary Ellen Martin, Hugh W Brock, et al.
Blood|August 1, 2013
MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interactionAndrew G Muntean, Wei Chen, Morgan Jones, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|August 17, 2022
Medical School Without Walls: 50 Years of Regional Campuses at Indiana University School of MedicinePaul M Wallach, Deborah R Birnbaum, Elizabeth R Ryan, et al.
Cancer Research|August 3, 2007
Interaction of MLL amino terminal sequences with menin is required for transformationCorrado Caslini, Zhaohai Yang, Mohamad El-Osta, et al.
Cancer Cell|November 19, 2011
CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesisJiaying Tan, Morgan Jones, Haruhiko Koseki, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2005
MLL associates specifically with a subset of transcriptionally active target genesThomas A Milne, Yali Dou, Mary Ellen Martin, et al.
Cell Reports|April 30, 2013
MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cellsEmanuel Maethner, Maria-Paz Garcia-Cuellar, Constanze Breitinger, et al.
Oncogene|April 28, 2005
The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatinDeniz T Zeisig, Claudia B Bittner, Bernd B Zeisig, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|September 3, 2013
Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteinsChenxi Shen, Stephanie Y Jo, Chenzhong Liao, et al.
Blood|March 15, 2011
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocationStephanie Y Jo, Eric M Granowicz, Ivan Maillard, et al.
Cancer Research|December 17, 2005
Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modificationsThomas A Milne, Mary Ellen Martin, Hugh W Brock, et al.
Blood|August 1, 2013
MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interactionAndrew G Muntean, Wei Chen, Morgan Jones, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|August 17, 2022
Medical School Without Walls: 50 Years of Regional Campuses at Indiana University School of MedicinePaul M Wallach, Deborah R Birnbaum, Elizabeth R Ryan, et al.
Cancer Research|August 3, 2007
Interaction of MLL amino terminal sequences with menin is required for transformationCorrado Caslini, Zhaohai Yang, Mohamad El-Osta, et al.
Cancer Cell|November 19, 2011
CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesisJiaying Tan, Morgan Jones, Haruhiko Koseki, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2005
MLL associates specifically with a subset of transcriptionally active target genesThomas A Milne, Yali Dou, Mary Ellen Martin, et al.
Cell Reports|April 30, 2013
MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cellsEmanuel Maethner, Maria-Paz Garcia-Cuellar, Constanze Breitinger, et al.
Oncogene|April 28, 2005
The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatinDeniz T Zeisig, Claudia B Bittner, Bernd B Zeisig, et al.
Pageof 7